The global
assisted reproductive technology (ART) market is poised to grow by USD 6.31
billion during 2020-2024, progressing at a CAGR of over 4% during the forecast
period.
The market is driven by the increase in rate of infertility and obesity
related cases. In addition, the increase in awareness of ART is anticipated to
boost the growth of the assisted reproductive technology market.
Modern work culture involves minimal physical activity. This is leading
to an increase in infertility cases among both men and women. Mental stress,
more desk work, consumption of alcohol and drugs, and hectic work schedules are
some other factors that have an adverse effect on health and leads to
infertility. Age is another determinant for fertility rate in men and women.
Obesity is a known risk factor responsible for low sperm count in men and
ovulation infertility in women, which is further increasing the infertility
rate across the globe. This is propelling both women and men to opt for
fertility services. Consequently, the demand for assisted reproductive
technology is increasing as it involves procedures such as intracytoplasmic
sperm injection and vitro fertilization to address infertility. Thus, the
increase in rate of infertility and obesity related cases is expected to drive
market growth during the forecast period.
Buy 1 Technavio report and get the second
for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Assisted Reproductive Technology Market Companies:
Anecova SA
Anecova SA generates revenue by the sale of a porous capsule, AneVivo
device, which is used for providing assisted reproductive technology (ART)
treatment. AneVivo is a device, which enables in vivo development in the
natural physiological environment of the maternal womb.
CRITEX GmbH
CRITEX GmbH offers products through the following business units: IT
CONSULTING, SOFTWARE DEVELOPMENT, and HEALTHCARE IT. The company offers
all-in-one IT solution for reproductive medicine. This IT solution includes
interfaces for ultrasound devices, practice management and hospital information
system, and laboratory diagnostics.
Esco Micro Pte. Ltd
Esco Micro Pte. Ltd operates under various business segments, namely
Life Sciences, Medical, and Healthcare. The company offers Multi-Zone ART
Workstation Class II. This device is used to handle gametes and embryos and is
equipped with integrated MIRI chambers and built-in microscope.
FUJIFILM Holdings Corp.
FUJIFILM Holdings Corp. offers products through the following business
segments: Imaging solutions, Healthcare and material solutions, and Document
solutions. The company offers ART Procedures. This procedure includes cryopreservation,
oocyte handling, embryo transfer, embryo culture, fertilization, and sperm
processing procedures.
INVO Bioscience Inc
INVO Bioscience Inc generates revenue through the provision of
infertility treatment using patented medical device. The company provides
INVOcell, which is used for the treatment of infertility. This product is an
intravaginal culture system.
No comments:
Post a Comment